Filter posts

UK Bioscience Forum: Confronting Common Challenges

This week, BIO’s President and CEO Jim Greenwood delivered a plenary address to attendees at …

BIO Patient and Health Advocacy Summit: Patient-Focused Drug Development

Panelists in this morning’s opening session outlined strategies for the FDA to better engage the …

BIO Investor Forum Kicks Off Amid Industry Optimism

Today, the BIO Investor Forum kicks off in San Francisco, Calif. BioWorld’s Catherine Shaffer paints …

JOBS Act Deconstructed: Regulatory Relief

More than 40 biotech companies have gone public using provisions made available to emerging growth …

JOBS Act Deconstructed: Regulation D

More than 40 biotech companies have gone public using provisions made available to emerging growth …

JOBS Act: Rule 506 Goes Into Effect Today

Since Congress passed the Jumpstart our Business Startups (JOBS) Act last spring, there have been …

Putting Patients First: Paving a Path to Useful CER

Comparative effectiveness research (CER) has the potential to improve health outcomes by helping people make …

FDA Consumer Update: Advances in Saving Lives with Blood

Every two seconds in the U.S., someone needs a blood transfusion or blood product—people of …

Exploring New Solutions For Neglected Diseases in Developing Countries

On Tuesday, BIO Ventures for Global Health (BVGH) announced the completion of the 30th research agreement …

BioCentury This Week: Death & Taxes – Startups Need Fixes

Vitae CEO Jeff Hatfield, Ernst & Young Partner Christopher Ohmes, and GPB Scientific CEO Michael …